Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (138)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Anto, R. J.
Right arrow Articles by Aggarwal, B. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Anto, R. J.
Right arrow Articles by Aggarwal, B. B.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Carcinogenesis, Vol. 23, No. 1, 143-150, January 2002
© 2002 Oxford University Press


CARCINOGENESIS

Curcumin (diferuloylmethane) induces apoptosis through activation of caspase-8, BID cleavage and cytochrome c release: its suppression by ectopic expression of Bcl-2 and Bcl-xl

Ruby John Anto, Asok Mukhopadhyay, Kate Denning and Bharat B. Aggarwal,1

Cytokine Research Section, Department of Bioimmunotherapy, Box 143, The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030, USA

Pharmacologically safe compounds that can inhibit the proliferation of tumor cells have potential as anticancer agents. Curcumin, a diferuloylmethane, is a major active component of the food flavor turmeric (Curcuma longa) that has been shown to inhibit the proliferation of a wide variety of tumor cells. The apoptotic intermediates through which curcumin exhibits its cytotoxic effects against tumor cells are not known, and the participation of antiapoptotic proteins Bcl-2 or Bcl-xl in the curcumin-induced apoptosis pathway is not established. In the present report we investigated the effect of curcumin on the activation of the apoptotic pathway in human acute myelogenous leukemia HL-60 cells and in established stable cell lines expressing Bcl-2 and Bcl-xl. Curcumin inhibited the growth of HL-60 cells (neo) in a dose- and time-dependent manner, whereas Bcl-2 and Bcl-xl-transfected cells were relatively resistant. Curcumin activated caspase-8 and caspase-3 in HL-60 neo cells but not in Bcl-2 and Bcl-xl-transfected cells. Similarly, time-dependent poly(ADP)ribose polymerase (PARP) cleavage by curcumin was observed in neo cells but not in Bcl-2 and Bcl-xl-transfected cells. Curcumin treatment also induced BID cleavage and mitochondrial cytochrome c release in neo cells but not in Bcl-2 and Bcl-xl-transfected cells. In neo HL-60 cells, curcumin also downregulated the expression of cyclooxygenase-2. Because DN-FLICE blocked curcumin-induced apoptosis, caspase-8 must play a critical role. Overall, our results indicate that curcumin induces apoptosis through mitochondrial pathway involving caspase-8, BID cleavage, cytochrome c release, and caspase-3 activation. Our results also suggest that Bcl-2 and Bcl-xl are critical negative regulators of curcumin-induced apoptosis.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
EndocrinologyHome page
M. Miller, S. Chen, J. Woodliff, and S. Kansra
Curcumin (Diferuloylmethane) Inhibits Cell Proliferation, Induces Apoptosis, and Decreases Hormone Levels and Secretion in Pituitary Tumor Cells
Endocrinology, August 1, 2008; 149(8): 4158 - 4167.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
N. Dhillon, B. B. Aggarwal, R. A. Newman, R. A. Wolff, A. B. Kunnumakkara, J. L. Abbruzzese, C. S. Ng, V. Badmaev, and R. Kurzrock
Phase II Trial of Curcumin in Patients with Advanced Pancreatic Cancer
Clin. Cancer Res., July 15, 2008; 14(14): 4491 - 4499.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
G. Chadalapaka, I. Jutooru, S. Chintharlapalli, S. Papineni, R. Smith III, X. Li, and S. Safe
Curcumin Decreases Specificity Protein Expression in Bladder Cancer Cells
Cancer Res., July 1, 2008; 68(13): 5345 - 5354.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
P. R. van Ginkel, S. R. Darjatmoko, D. Sareen, L. Subramanian, S. Bhattacharya, M. J. Lindstrom, D. M. Albert, and A. S. Polans
Resveratrol Inhibits Uveal Melanoma Tumor Growth via Early Mitochondrial Dysfunction
Invest. Ophthalmol. Vis. Sci., April 1, 2008; 49(4): 1299 - 1306.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
P. R. van Ginkel, D. Sareen, L. Subramanian, Q. Walker, S. R. Darjatmoko, M. J. Lindstrom, A. Kulkarni, D. M. Albert, and A. S. Polans
Resveratrol Inhibits Tumor Growth of Human Neuroblastoma and Mediates Apoptosis by Directly Targeting Mitochondria
Clin. Cancer Res., September 1, 2007; 13(17): 5162 - 5169.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
S. K. Sandur, M. K. Pandey, B. Sung, K. S. Ahn, A. Murakami, G. Sethi, P. Limtrakul, V. Badmaev, and B. B. Aggarwal
Curcumin, demethoxycurcumin, bisdemethoxycurcumin, tetrahydrocurcumin and turmerones differentially regulate anti-inflammatory and anti-proliferative responses through a ROS-independent mechanism
Carcinogenesis, August 1, 2007; 28(8): 1765 - 1773.
[Abstract] [Full Text] [PDF]


Home page
Evid Based Complement Alternat MedHome page
S. Salvioli, E. Sikora, E. L. Cooper, and C. Franceschi
Curcumin in Cell Death Processes: A Challenge for CAM of Age-Related Pathologies
Evid. Based Complement. Altern. Med., June 1, 2007; 4(2): 181 - 190.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
D. Y. Jun, J. S. Kim, H. S. Park, C. R. Han, Z. Fang, M. H. Woo, I. K. Rhee, and Y. H. Kim
Apoptogenic activity of auraptene of Zanthoxylum schinifolium toward human acute leukemia Jurkat T cells is associated with ER stress-mediated caspase-8 activation that stimulates mitochondria-dependent or -independent caspase cascade
Carcinogenesis, June 1, 2007; 28(6): 1303 - 1313.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
D. Deeb, H. Jiang, X. Gao, S. Al-Holou, A. L. Danyluk, S. A. Dulchavsky, and S. C. Gautam
Curcumin [1,7-Bis(4-hydroxy-3-methoxyphenyl)-1-6-heptadine-3,5-dione; C21H20O6] Sensitizes Human Prostate Cancer Cells to Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand/Apo2L-Induced Apoptosis by Suppressing Nuclear Factor-{kappa}B via Inhibition of the Prosurvival Akt Signaling Pathway
J. Pharmacol. Exp. Ther., May 1, 2007; 321(2): 616 - 625.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. B. Kunnumakkara, S. Guha, S. Krishnan, P. Diagaradjane, J. Gelovani, and B. B. Aggarwal
Curcumin Potentiates Antitumor Activity of Gemcitabine in an Orthotopic Model of Pancreatic Cancer through Suppression of Proliferation, Angiogenesis, and Inhibition of Nuclear Factor-{kappa}B-Regulated Gene Products
Cancer Res., April 15, 2007; 67(8): 3853 - 3861.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
M. Moussavi, K. Assi, A. Gomez-Munoz, and B. Salh
Curcumin mediates ceramide generation via the de novo pathway in colon cancer cells
Carcinogenesis, August 1, 2006; 27(8): 1636 - 1644.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
M. M. LoTempio, M. S. Veena, H. L. Steele, B. Ramamurthy, T. S. Ramalingam, A. N. Cohen, R. Chakrabarti, E. S. Srivatsan, and M. B. Wang
Curcumin Suppresses Growth of Head and Neck Squamous Cell Carcinoma
Clin. Cancer Res., October 1, 2005; 11(19): 6994 - 7002.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
N. Jurrmann, R. Brigelius-Flohe, and G.-F. Bol
Curcumin Blocks Interleukin-1 (IL-1) Signaling by Inhibiting the Recruitment of the IL-1 Receptor-Associated Kinase IRAK in Murine Thymoma EL-4 Cells
J. Nutr., August 1, 2005; 135(8): 1859 - 1864.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
R. Rashmi, S. Kumar, and D. Karunagaran
Human colon cancer cells lacking Bax resist curcumin-induced apoptosis and Bax requirement is dispensable with ectopic expression of Smac or downregulation of Bcl-XL
Carcinogenesis, April 1, 2005; 26(4): 713 - 723.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. V. Bava, V. T. Puliappadamba, A. Deepti, A. Nair, D. Karunagaran, and R. J. Anto
Sensitization of Taxol-induced Apoptosis by Curcumin Involves Down-regulation of Nuclear Factor-{kappa}B and the Serine/Threonine Kinase Akt and Is Independent of Tubulin Polymerization
J. Biol. Chem., February 25, 2005; 280(8): 6301 - 6308.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
X. WANG, J. ZHANG, H. P. KIM, Y. WANG, A. M. K. CHOI, and S. W. RYTER
Bcl-XL disrupts death-inducing signal complex formation in plasma membrane induced by hypoxia/reoxygenation
FASEB J, December 1, 2004; 18(15): 1826 - 1833.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
R. Rashmi, S. Kumar, and D. Karunagaran
Ectopic expression of Bcl-XL or Ku70 protects human colon cancer cells (SW480) against curcumin-induced apoptosis while their down-regulation potentiates it
Carcinogenesis, October 1, 2004; 25(10): 1867 - 1877.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
E. Rosati, R. Sabatini, E. Ayroldi, A. Tabilio, A. Bartoli, S. Bruscoli, C. Simoncelli, R. Rossi, and P. Marconi
Apoptosis of human primary B lymphocytes is inhibited by N-acetyl-L-cysteine
J. Leukoc. Biol., July 1, 2004; 76(1): 152 - 161.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
D. Deeb, H. Jiang, X. Gao, M. S. Hafner, H. Wong, G. Divine, R. A. Chapman, S. A. Dulchavsky, and S. C. Gautam
Curcumin sensitizes prostate cancer cells to tumor necrosis factor-related apoptosis-inducing ligand/Apo2L by inhibiting nuclear factor-{kappa}B through suppression of I{kappa}B{alpha} phosphorylation
Mol. Cancer Ther., July 1, 2004; 3(7): 803 - 812.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. R. Jana, P. Dikshit, A. Goswami, and N. Nukina
Inhibition of Proteasomal Function by Curcumin Induces Apoptosis through Mitochondrial Pathway
J. Biol. Chem., March 19, 2004; 279(12): 11680 - 11685.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
R. Rashmi, S. Kumar, and D. Karunagaran
Ectopic expression of Hsp70 confers resistance and silencing its expression sensitizes human colon cancer cells to curcumin-induced apoptosis
Carcinogenesis, February 1, 2004; 25(2): 179 - 187.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Y.-G. Hur, Y. Yun, and J. Won
Rosmarinic Acid Induces p56lck-Dependent Apoptosis in Jurkat and Peripheral T Cells via Mitochondrial Pathway Independent from Fas/Fas Ligand Interaction
J. Immunol., January 1, 2004; 172(1): 79 - 87.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. C. Bharti, N. Donato, S. Singh, and B. B. Aggarwal
Curcumin (diferuloylmethane) down-regulates the constitutive activation of nuclear factor-kappa B and Ikappa Balpha kinase in human multiple myeloma cells, leading to suppression of proliferation and induction of apoptosis
Blood, February 1, 2003; 101(3): 1053 - 1062.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
D. Deeb, Y. X. Xu, H. Jiang, X. Gao, N. Janakiraman, R. A. Chapman, and S. C. Gautam
Curcumin (Diferuloyl-Methane) Enhances Tumor Necrosis Factor-related Apoptosis-inducing Ligand-induced Apoptosis in LNCaP Prostate Cancer Cells
Mol. Cancer Ther., January 1, 2003; 2(1): 95 - 103.
[Abstract] [Full Text] [PDF]


Home page
ASH Education BookHome page
Z.-y. Wang
Ham-Wasserman Lecture: Treatment of Acute Leukemia by Inducing Differentiation and Apoptosis
Hematology, January 1, 2003; 2003(1): 1 - 13.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Gajate, F. An, and F. Mollinedo
Differential Cytostatic and Apoptotic Effects of Ecteinascidin-743 in Cancer Cells. TRANSCRIPTION-DEPENDENT CELL CYCLE ARREST AND TRANSCRIPTION-INDEPENDENT JNK AND MITOCHONDRIAL MEDIATED APOPTOSIS
J. Biol. Chem., October 25, 2002; 277(44): 41580 - 41589.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
X. Tang, Y. J. Sun, E. Half, M. T. Kuo, and F. Sinicrope
Cyclooxygenase-2 Overexpression Inhibits Death Receptor 5 Expression and Confers Resistance to Tumor Necrosis Factor-related Apoptosis-inducing Ligand-induced Apoptosis in Human Colon Cancer Cells
Cancer Res., September 1, 2002; 62(17): 4903 - 4908.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.